These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 23611358)
1. The prognostic impact of human leukocyte antigen (HLA) class I antigen abnormalities in salivary gland cancer. A clinicopathological study of 288 cases. Müller M; Agaimy A; Zenk J; Ettl T; Iro H; Hartmann A; Seliger B; Schwarz S Histopathology; 2013 May; 62(6):847-59. PubMed ID: 23611358 [TBL] [Abstract][Full Text] [Related]
2. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors. Facoetti A; Nano R; Zelini P; Morbini P; Benericetti E; Ceroni M; Campoli M; Ferrone S Clin Cancer Res; 2005 Dec; 11(23):8304-11. PubMed ID: 16322289 [TBL] [Abstract][Full Text] [Related]
3. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma. Mehta AM; Jordanova ES; Kenter GG; Ferrone S; Fleuren GJ Cancer Immunol Immunother; 2008 Feb; 57(2):197-206. PubMed ID: 17622526 [TBL] [Abstract][Full Text] [Related]
4. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer. Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355 [TBL] [Abstract][Full Text] [Related]
5. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation. Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726 [TBL] [Abstract][Full Text] [Related]
6. Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer. Ayshamgul H; Ma H; Ilyar S; Zhang LW; Abulizi A Chin Med J (Engl); 2011 Feb; 124(3):341-6. PubMed ID: 21362330 [TBL] [Abstract][Full Text] [Related]
7. HLA class I is most tightly linked to levels of tapasin compared with other antigen-processing proteins in glioblastoma. Thuring C; Follin E; Geironson L; Freyhult E; Junghans V; Harndahl M; Buus S; Paulsson KM Br J Cancer; 2015 Sep; 113(6):952-62. PubMed ID: 26313662 [TBL] [Abstract][Full Text] [Related]
8. Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin. Delp K; Momburg F; Hilmes C; Huber C; Seliger B Bone Marrow Transplant; 2000 May; 25 Suppl 2():S88-95. PubMed ID: 10933198 [TBL] [Abstract][Full Text] [Related]
9. [Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in laryngeal squamous cell carcinoma]. Zeng Q; Wang XL; Xu ZG; Lü N; Zheng S; Zhao QZ; Tang PZ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):234-40. PubMed ID: 22805026 [TBL] [Abstract][Full Text] [Related]
10. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors. Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570 [TBL] [Abstract][Full Text] [Related]
11. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome. Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633 [TBL] [Abstract][Full Text] [Related]
12. Prominence of beta 2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. Solheim JC; Harris MR; Kindle CS; Hansen TH J Immunol; 1997 Mar; 158(5):2236-41. PubMed ID: 9036970 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression. Kageshita T; Hirai S; Ono T; Hicklin DJ; Ferrone S Am J Pathol; 1999 Mar; 154(3):745-54. PubMed ID: 10079252 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer. Leffers N; Gooden MJ; Mokhova AA; Kast WM; Boezen HM; Ten Hoor KA; Hollema H; Daemen T; van der Zee AG; Nijman HW Gynecol Oncol; 2009 May; 113(2):256-63. PubMed ID: 19243813 [TBL] [Abstract][Full Text] [Related]
15. Distinct differences in association of MHC class I with endoplasmic reticulum proteins in wild-type, and beta 2-microglobulin- and TAP-deficient cell lines. Paulsson KM; Wang P; Anderson PO; Chen S; Pettersson RF; Li S Int Immunol; 2001 Aug; 13(8):1063-73. PubMed ID: 11470776 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma? Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847 [TBL] [Abstract][Full Text] [Related]
17. Identification of domain boundaries within the N-termini of TAP1 and TAP2 and their importance in tapasin binding and tapasin-mediated increase in peptide loading of MHC class I. Procko E; Raghuraman G; Wiley DC; Raghavan M; Gaudet R Immunol Cell Biol; 2005 Oct; 83(5):475-82. PubMed ID: 16174096 [TBL] [Abstract][Full Text] [Related]
18. TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis. Kamarashev J; Ferrone S; Seifert B; Böni R; Nestle FO; Burg G; Dummer R Int J Cancer; 2001 Jan; 95(1):23-8. PubMed ID: 11241306 [TBL] [Abstract][Full Text] [Related]
19. WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism? Mehling M; Simon P; Mittelbronn M; Meyermann R; Ferrone S; Weller M; Wiendl H Acta Neuropathol; 2007 Aug; 114(2):111-9. PubMed ID: 17541610 [TBL] [Abstract][Full Text] [Related]
20. Expression of transporters associated with antigen processing and human leucocyte antigen class I in malignant melanoma and its association with prognostic factors. Tao J; Li Y; Liu YQ; Li L; Liu J; Shen X; Shen GX; Tu YT Br J Dermatol; 2008 Jan; 158(1):88-94. PubMed ID: 17999701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]